264 related articles for article (PubMed ID: 6139020)
21. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
Holzer H; Pogglitsch H; Katschnig H; Korthals C
Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
[TBL] [Abstract][Full Text] [Related]
22. Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension.
Smith WB; Clifton GG; O'Neill WM; Wallin JD
Hypertension; 1983; 5(4):579-83. PubMed ID: 6862581
[TBL] [Abstract][Full Text] [Related]
23. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF
Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
Scardo JA; Vermillion ST; Newman RB; Chauhan SP; Hogg BB
Am J Obstet Gynecol; 1999 Oct; 181(4):862-6. PubMed ID: 10521743
[TBL] [Abstract][Full Text] [Related]
25. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
Milne BJ; Logan AG
Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
[TBL] [Abstract][Full Text] [Related]
27. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
[TBL] [Abstract][Full Text] [Related]
28. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
Weber MA; Drayer JI; Kaufman CA
J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
[TBL] [Abstract][Full Text] [Related]
29. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
[TBL] [Abstract][Full Text] [Related]
30. Treatment of severe hypertension with intravenous labetalol.
Papademetriou V; Notargiacomo AV; Khatri IM; Freis ED
Clin Pharmacol Ther; 1982 Oct; 32(4):431-5. PubMed ID: 7116758
[TBL] [Abstract][Full Text] [Related]
31. Intravenous labetalol in severe hypertension.
Dal Palu C; Pessina AC; Semplicini A; Hlede M; Morandin F; Palatini P; Sperti G; Rossi GP
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):97S-99S. PubMed ID: 7093106
[TBL] [Abstract][Full Text] [Related]
32. Labetalol in the treatment of hypertension in elderly and younger patients.
Abernethy DR; Bartos P; Plachetka JR
J Clin Pharmacol; 1987 Nov; 27(11):902-6. PubMed ID: 2892866
[TBL] [Abstract][Full Text] [Related]
33. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
[TBL] [Abstract][Full Text] [Related]
34. Rapid onset of action of oral labetalol in severe hypertension.
Ghose RR; Sampson A
Curr Med Res Opin; 1977; 5(2):147-51. PubMed ID: 340130
[TBL] [Abstract][Full Text] [Related]
35. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
[TBL] [Abstract][Full Text] [Related]
36. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
Gaynor MF; Wright GC; Vondracek S
Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
[TBL] [Abstract][Full Text] [Related]
37. Intravenous labetalol in hypertensive emergency.
Cumming AM; Davies DL
Lancet; 1979 Apr; 1(8122):929-30. PubMed ID: 86702
[No Abstract] [Full Text] [Related]
38. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
Pearson RM; Havard CW
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
[TBL] [Abstract][Full Text] [Related]
39. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
[TBL] [Abstract][Full Text] [Related]
40. Study of single and multiple dose pharmacokinetic/pharmacodynamic modeling of the antihypertensive effects of labetalol.
Maronde RF; Robinson D; Vlachakis ND; Barr JW; Chung M; Zampaglione N; Medakovic M
Am J Med; 1983 Oct; 75(4A):40-6. PubMed ID: 6356898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
